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Early neuropathological changes characteristic of late-onset Alzheimer’s disease (LOAD)
involve brain stem and limbic structures that regulate neurovegetative functions,
including sleep–wake rhythm. Indeed, sleep pattern is an emerging biomarker and a
potential pathophysiological mechanism in LOAD. We hypothesized that cognitively
asymptomatic, middle-aged offspring of patients with LOAD (O-LOAD) would display
a series of circadian rhythm abnormalities prior to the onset of objective cognitive
alterations. We tested 31 children of patients with LOAD (O-LOAD) and 19 healthy
individuals without family history of Alzheimer’s disease (control subjects, CS) with basic
tests of cognitive function, as well as actigraphy measures of sleep–wake rhythm,
cardiac autonomic function, and bodily temperature. Unexpectedly, O-LOAD displayed
subtle but significant deficits in verbal episodic memory (Rey Auditory Verbal Learning
Test delayed recall 10.6 ± 0.4 vs. 8.6 ± 0.6, t = 4.97, df = 49, p < 0.01) and
language (Weschler’s vocabulary 51.4 ± 1.3 vs. 44.3 ± 1.5, t = 2.49, df = 49,
p < 0.001) compared to CS, even though all participants had results within the
clinically normal range. O-LOAD showed a phase-delayed rhythm of body temperature
(2.56 ± 0.47 h vs. 3.8 ± 0.26 h, t = 2.48, df = 40, p = 0.031). Cognitive performance
in O-LOAD was associated with a series of cardiac autonomic sleep–wake variables;
specifically indicators of greater sympathetic activity at night were related to poorer
cognition. The present results suggest sleep pattern deserves further study as a
potential neurobiological signature in LOAD, even in middle-aged, at risk individuals.
Keywords: early diagnosis, late-onset Alzheimer’s disease, circadian rhythms, cardiac autonomic control,
actigraphy
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INTRODUCTION
Alzheimer’s disease (AD) is a progressive neurodegenerative
disorder that causes up to 80% of all dementia cases worldwide
(Alzheimer’s Association, 2016). It is characterized by the
coexistence of two neuropathological hallmarks, namely
extracellular plaques of amyloid beta (Aβ) and intracellular
neurofibrillary tangles made up of hyperphosphorylated Tau
protein (Tau). Severe neurodegeneration and widespread
neuroinflammation are ubiquitous albeit less specific
neuropathological features of the disorder. Over 99% of AD cases
are late-onset (i.e., the initial cognitive symptoms usually appear
after 65 years of age); familial or early-onset AD cases result from
fairly rare autosomal dominant mutations, and account for less
than 1% of cases, including the patient of the original description
of the disorder (Alzheimer, 1907). The relationship between Aβ-
and Tau-related pathology in AD is complex and remains elusive
in its details to this day. The amyloid cascade hypothesis (ACH)
posits that AD begins with the deposition of Aβ, resulting from
increased production, reduced clearance, or a combination or
both. The deposition of Aβ would in turn trigger a cascade of
neurodegenerative processes including Tau-related intracellular
changes, loss of synapses, inflammation neurodegeneration, and
eventually regional brain atrophy (Hardy and Higgins, 1992).
The ACH got support from evidence that familial forms of
AD were due to dominant mutations in enzymes participating
in the metabolism of amyloid. Down syndrome [resulting in
an extra copy of the gene coding for the amyloid precursor
protein (APP) located in chromosome 21], which is associated
with increased incidence and earlier onset of AD, lent further
support to the ACH. However, the main conceptual problem
of this hypothesis is a remarkable lack of correlation between
Aβ deposits and cognitive changes, as well as the absence of
a clear and orderly pattern of anatomical progression as the
disease advances. Further, significant in vivo Aβ deposition is
present in a substantial number of cognitively normal elderly
individuals, and it is associated with gray matter (GM) changes
not characteristic of the early phases of neurodegeneration of AD
(Sepulcre et al., 2016). In spite of this evident lack of correlation
between Aβ deposition and cognitive symptoms, a number of
pharmacological agents targeting Aβ accumulation have failed or
even resulted in worse outcomes than placebo. In fact, this group
of experimental drugs (including anti-Aβ antibodies seeking to
improve clearance of brain amyloid, and drugs interfering with
the synthesis of new amyloid) have met with one of the highest
failure rates in any therapeutic area in the history of medicine
(Cummings et al., 2014).
On the other hand, Tau pathology in AD follows a highly
predictable progression, predates Aβ accumulation in anatomical
studies, and shows a parsimonious relationship with cognitive
symptom development (Braak and Del Tredici, 2011; Walsh et al.,
2017) being the basis for the most accepted staging system of AD
pathology (Braak and Braak, 1991).
Early detection of cases of AD, before any cognitive symptoms
emerge, is a challenge as important as discovering treatments
aimed at the causes of AD. This should be accomplished before
neuropathological changes are so advanced that they cannot
be reversed. In fact neuropathological studies suggest changes
characteristic of AD occur already in the third and fourth decades
of life, involving phosphorylated Tau accumulation in selected
groups of neurons, including those in the locus coeruleus,
and diencephalic and allocortical limbic areas (Braak and Del
Tredici, 2011; Buchhave et al., 2012). Such areas are involved
in the regulation of vegetative functions, including autonomic
nervous system regulation and diurnal variation (Braak et al.,
2011). Sleep–wake cycle regulation in particular, depends on
intrinsic circadian rhythm generation by diencephalic structures,
in addition to a series of environmental cues of sleep–wake cycle
(Buijs et al., 2016). Thus, alterations in sleep could represent,
in theory, early manifestations of late-onset AD (LOAD)-related
neuropathological changes in the brain.
Sleep abnormalities have emerged as potential early
biomarkers of LOAD status (see Mander et al., 2016 for a
review on this topic). AD-related changes in sleep have also
been proposed as possible neuropathogenic mediators that
perpetuate the cycle of amyloid deposition, neurofibrillar
changes, and neurodegeneration ultimately resulting in cognitive
and functional deterioration (Lim et al., 2013; Mander et al.,
2015). In addition, previous evidence suggests that in cognitively
asymptomatic, middle-aged individuals, amyloid deposition is
associated with poor sleep (Sprecher et al., 2015).
We hypothesized that circadian alterations could be an
early functional manifestation of AD neuropathology in at-risk
individuals. To this end, we studied a group of cognitively
normal, middle-aged individuals with at least one parent
diagnosed with LOAD, which accounts for over 99% of all
cases of AD (Dubois et al., 2016). We specifically predicted that
cognitively asymptomatic offspring of LOAD patients (O-LOAD)
would display abnormalities in sleep, circadian autonomic
activity and diurnal variation, and circadian rhythm of body
temperature as compared with healthy individuals without a
family history of AD. Moreover, we expected to find correlations
between such circadian alterations (in the form of decreased
amplitude of diurnal variation, phase alterations, sleep efficiency,
and greater sympathetic or lesser parasympathetic activity), and
cognitive performance in verbal memory in O-LOAD but not
healthy individuals.
MATERIALS AND METHODS
Design and Sample
This was a cross-sectional study, where cognitive and
chronobiological measures were compared between a sample of
AD offspring (O-LOAD) and control subjects (CS). The study
protocol was performed in accordance with the Declaration of
Helsinki, and approved by the Bioethics Committee of FLENI
Foundation, Argentina. All participants provided their written
informed consent for the study.
A total of 31 O-LOAD participated in the study along with 19
healthy subjects with no family history of AD (CS), consecutively
selected and comparable in gender, age, and education level.
The inclusion criteria for O-LOAD were as follows: (1) To have
at least one parent diagnosed with probable LOAD according
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to the DSM-5, (2) to be 40–65 years old at the time of
recruitment, and (3) seven or more years of formal education.
The CS group had the same inclusion criteria except for item
1). The exclusion criteria for O-LOAD and CS were as follows:
(1) Mini Mental State Examination (MMSE) score <25, (2)
compromised intellectual level based education and employment
history, (3) evidence of current progressive neurologic disease or
likely to impair cognitive performance, (4) history of substance
abuse (alcohol, marijuana, stimulants, benzodiazepines, or other
drugs), and (5) Hachinski score >7 (to filter data suggestive of
vascular-derived cognitive impairment).
Cognitive Assessment
The neuropsychological tests selected for this study have been
widely validated and are frequently used in clinical practice
and thus require no detailed explanation. They comprise a
concise battery aimed at assessing the most salient cognitive
domains impaired in AD: episodic memory and language.
Neuropsychological evaluation was performed in a single session
of approximately 90 min by an experienced neuropsychologist
(CA). All evaluations were performed between 12.00 and 17.00 h.
The MMSE (Folstein et al., 1975) and the Clock Drawing
Test subtest from the 7 Minute Screen test (Solomon et al.,
1998) were included as screening measurements; whereas MMSE
is insensitive to even prodromal AD, we incorporated it as
a widely used screening instrument (Ravaglia et al., 2005),
to be complemented with more sensitive tests. Thus, verbal
episodic memory was assessed by the Rey Auditory Verbal
Learning Test (RAVLT; Rey, 1964; Schmidt, 1996). Semantic
memory, or “the knowledge of words” was measured by the
semantic fluency task (“animals” category) (Spreen and Benton,
1969) and the vocabulary subtest of the intelligence battery
WAIS-III (Wechsler, 1997). Additionally, the Cognitive Reserve
Questionnaire (CRQ) was administered to all participants. This
technique proves to be quick and useful screening to assess
the most relevant elements associated to the cognitive reserve
(education level, parent’s education level, additional academic
courses completed, professional activity, musical education,
fluent languages, reading activity, and ingenuity games) (Rami
et al., 2011). Finally, the presence and severity of depressive
symptoms was measured by the Beck Depression Inventory (self-
report) and by the Hamilton Depression Rating Scale (HDRS)
completed by a clinician.
All participants were cognitively asymptomatic and their
neuropsychological testing yielded normal values, so none of
the individuals met criteria for mild cognitive impairment or
dementia.
Assessment of Neurovegetative Function
Two questionnaires were used to measure quality of sleep:
Pittsburgh Sleep Quality Index (PSQI) and Epworth Sleepiness
Scale (ESS). The PSQI is a self-report questionnaire that assesses
sleep problems in the last month. A PSQI score greater than
4 points is defined as “poor sleep quality.” The ESS measures
daytime sleepiness. An ESS score greater than 10 represents
“excessive daytime sleepiness” (Diez et al., 2011).
Objective evaluation of the sleep–wake cycle was performed
by actigraphy. Subjects wore the actigraph (MicroMini-
Motionlogger, Ambulatory Monitoring Inc, NY, USA) on their
wrist for 7 days. During this time, they were also requested
to complete a Daily Sleep Diary where they reported sleep
habits including sleep onset and offset. Time spent in bed, time
awake, and sleep efficiency were calculated using Action W 2.5
(Ambulatory Monitoring Inc, NY, USA) (Bellone et al., 2016).
Distal skin temperature was measured as a proxy for the
circadian rhythm of core temperature. There is an approximate
12-h phase difference between distal skin temperature and core
body temperature and both measures behave in the same manner,
reaching its maximum levels during the sleeping period and
decreasing during waking hours (Sarabia et al., 2008). For this
study, 16 mm× 6 mm Thermochron iButton R© DS1291H (Dallas
Maxim) sensors were placed next to the actigraph. Temperature
samples were obtained every 10 min for 7 days (van Marken
Lichtenbelt et al., 2006). The Chronos-Fit software was used to fit
a cosine curve with a 24-h period to the data as an estimate of the
circadian pattern, using the partial Fourier series method. From
that model, the following measures were derived: % rhythm:
represents the percentage of variation in the data explained by the
fitted model; MESOR (midline estimating statistic of rhythm) is
a rhythm adjusted mean; amplitude is the difference between the
maximum and the MESOR; acrophase is the time at which the
maximum of the rhythm occurs (van Marken Lichtenbelt et al.,
2006; Refinetti et al., 2007).
Autonomic nervous system circadian rhythm was measured
by heart rate variability (HRV) analysis described in detail
elsewhere (Vigo et al., 2005, 2010). Fluctuations in heartbeats
are cyclical and have different frequencies. High frequency
(HF) modifications respond to respiratory mechanisms and
are a marker of parasympathetic activity. Low frequency
(LF) fluctuations respond to the baroreflex and present
sympathetic and parasympathetic influences. There are also very
low frequency (VLF) oscillations, which possibly respond to
hormonal or thermal oscillations.
Participants underwent a 24-h digital electrocardiogram
(ECG) study (Holtech, Servicios Computados SA, Buenos Aires).
The data obtained were processed to calculate the time elapsed
between R waves (RR intervals). HRV evaluation consisted of
time domain and frequency domain analyses. For the time
domain analysis, the following measures were calculated: RRM
(mean duration of RR intervals in milliseconds) quantifies the
mean heart rate, SDNN (standard deviation of RR intervals
in milliseconds) represents a coarse quantification of overall
variability, and RMSSD (square root of the mean squared
differences of successive normal RR) measures short-term heart
rate variations. For the frequency domain analysis, the discrete
wavelet transform (DWT) was chosen over the traditional fast
Fourier transform because it is not affected by discontinuities
or non-stationarities. Before applying the DWT, the linear trend
and the mean value were subtracted from the signal. Moreover,
it was evenly sampled with a frequency of 2.4 Hz through a
spline interpolation algorithm and zero padded to the next higher
power of two. The signal was analyzed by a six-level wavelet
decomposition with a Daubechies four-wavelet function. After
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undergoing such a decomposition process, wavelet levels A6 and
D1–D6 make up the total power (TP, 0–0.5 Hz), wavelet levels A6
and D6 closely represent the VLF band (0–0.0375 Hz), wavelet
levels D4–D5 reflect the LF band (0.0375–0.15 Hz), and wavelet
levels D2–D3 approximate to the HF band (0.15–0.6 Hz). In
DWT, the square of the standard deviation of wavelet coefficients
at each level matches the spectral power of that level. The
obtained values are formulated as the natural logarithm of TP,
HF, LF, and VLF; normalized units of LF [LF/(TP − VLF)/100]
and HF [HF/(TP− VLF)/100]; and the ratio between LF and HF
(Vigo et al., 2012).
For the circadian analysis, the ECG recording was segmented
in 30-min fragments, which were then averaged according to the
sleep or wake periods as defined by actigraphy. Furthermore,
sleep–wake autonomic differences were calculated. Daytime sleep
periods were classified as naps and excluded from the daytime
average.
Structural MRI
MRI images were acquired on a 3 T GE Signa HDxt MRI
machine with an eight-channel head coil. A high resolution T1
3D fast SPGR-IR (TR = 6.604 ms, TE = 2.796 ms, TI = 450)
image was acquired. Image correction (ASSET) with acceleration
factor = 2; acquisition matrix = 256 × 256; FOV = 24 cm; slice
thickness= 1.2 mm; 120 axial contiguous slices.
The acquired images were converted from DICOM
format to NIFTI using the SPM12 (Wellcome Department
of Cognitive Neurology, London, UK) implemented in
MATLAB (MathWorks Inc., Sherborn, MA, USA). The
CAT12 tool1 for the SPM12 was used to process the images
(Preprocessing → Segment Data Batch with default parameter
values). A quality control of the images derived from the
segmentation was carried out and the relative volumes of GM
and white matter (WM) were obtained for each subject.
Statistical Analysis
Continuous variables were summarized by means and standard
errors. Categorical variables were summarized as frequencies
and percentages. Differences between groups were calculated
by using t-test for independent samples, and sex differences
in groups by means of the chi-square test. Correlations of
chronobiological measures with cognitive and clinical data were
evaluated using Pearson correlation coefficients. We report two-
tailed signification at p < 0.05 and also Bonferroni correction
for multiple comparisons. All statistical analysis was performed
using the SPSS version 22.0 software (SPSS Inc.).
RESULTS
Both groups were comparable in age (CS = 54.2 ± 2.2 years
vs. O-LOAD = 53.8 ± 1.6 years) and sex (CS 73.7% women
vs. O-LOAD 71%). Table 1 shows the demographic and clinical
characteristics of O-LOAD and CS. Groups had similar years of
education, Hachinski score, and depressive symptoms (Table 1).
1http://dbm.neuro.uni-jena.de/cat/
Whereas all participants had normal cognitive performance,
as a group, O-LOAD showed lower episodic memory as
evidenced by performance on the RAVLT (Table 2). The WAIS
vocabulary item was also lower among the O-LOAD (Table 2).
O-LOAD showed a delayed phase in the circadian rhythm of
body temperature compared to CS (Table 1). Measures of sleep–
wake cycle in the actigraphy, cardiac autonomic variables, and
relative GM and WM brain volumes were similar in both groups
as well (Table 1).
In CS, relative GM volume showed a direct correlation
with learning in RAVLT (r = 0.769, p = 0.001). We did not
observe a relationship between GM or WM volume and cognitive
performance variables in O-LOAD.
Table 2 shows significant correlations between HRV and its
diurnal variations and cognitive values in O-LOAD. Learning
and recall values on the RAVLT displayed robust correlations
with a series of cardiac autonomic activity measures and their
diurnal variations. In general, greater HRV and a greater night–
day difference in HRV resulted in better verbal memory results.
More specifically, an increased sympathovagal balance at night
was associated with poorer cognitive results on verbal memory,
clock drawing and MMSE score (Table 2). All associations
between frequency-domain HRV and RAVLT variables survived
Bonferroni corrections for multiple tests (Table 2, bold r, p).
These associations were not present in CS (not shown). Sleep
efficiency measured with actigraphy in O-LOAD was associated
with greater cognitive reserve (r = 0.495, p = 0.007). Such
correlations were again not present in CS (not shown).
DISCUSSION
The main findings of the present study include (1) lower
performance in O-LOAD as compared to CS in measures of
verbal memory and language, even though performance in both
groups falls within the normal range, (2) a delayed phase of
the circadian rhythm of body temperature in O-LOAD, (3) the
presence of a relationship between sleep efficiency and verbal
memory in O-LOAD, and (4) overall HRV, decreased night–day
differences in HRV, and increased sympathovagal balance at night
are all related to decreased verbal memory in O-LOAD.
The present observations of a relationship between indicators
of healthy circadian and neurovegetative function and cognitive
abilities in O-LOAD lend support to the hypothesis that sleep
characteristics are associated with changes in cognition typical
of AD, and that such a relationship is present over a decade
prior to the expected onset of cognitive symptoms. This is
compatible with the view that ongoing sleep changes, if persistent,
could contribute to the appearance of cognitive symptoms
characteristic of AD. Further, we observed a phase delay in the
diurnal rhythm of body temperature in O-LOAD, pointing to a
basic alteration in the circadian system in this group. Moreover,
our findings extend this observation to sleep–wake differences
in sympathovagal balance, another limbic phenotype with a
potential relationship with early AD pathological changes. HRV is
a non-invasive measure of cardiac autonomic output, ultimately
reflecting complex regulation at the central autonomic network
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TABLE 1 | Demographic and clinical data.
CS O-LOAD
Mean or frequency SE or % Mean or frequency SE or % t p
Demographic and clinical data
n 19 31
Education 17.1 1.2 16.3 0.4 10.732 0.564
CRQ 17.2 0.7 15.3 0.7 1.227 0.071
Hachinski score 1.1 0.3 1.2 0.2 1.172 0.667
BDI-II 9.1 1.9 8.8 1.2 0.068 0.903
HDRS 7.9 1.3 8.8 1.3 0.927 0.635
PSQI 5.7 0.9 6.3 0.7 0.431 0.548
ESS 8.9 1.0 9.3 0.8 0.044 0.808
Neuropsychological tests
n 19 31
MMSE 29.3 0.2 28.9 0.2 1.152 0.103
Clock 5.9 0.3 6.0 0.2 0.280 0.806
Vocabulary 51.4 1.3 44.3 1.5 2.486 0.001
Semantic fluency 21.4 1.3 20.7 0.7 3.474 0.644
RAVLT 45.6 2.2 42.9 1.3 2.271 0.293
RAVLT D 10.6 0.4 8.6 0.6 4.974 0.009
Brain volume
n 15 27
RGM (%) 42.83 0.52 42.74 0.31 1.158 0.880
RWM (%) 34.19 0.37 34.46 0.30 0.342 0.582
Actigraphy
n 17 28
Start time (hh:mm) 00:43 00:14 00:00 00:14 0.669 0.097
End time (hh:mm) 07:55 00:14 07:55 00:14 1.096 0.922
Duration (min) 443.91 12.47 473.70 11.79 0.033 0.090
Efficiency (%) 95.85 0.92 95.64 0.46 0.618 0.839
Distal temperature
n 15 26
% rhythm 26.69 3.95 26.40 2.60 0.157 0.952
MESOR 33.03 0.14 32.16 1.15 1.584 0.456
Amplitude (◦C) 0.99 0.11 0.96 0.09 0.052 0.841
Acrophase (time) 2.56 0.47 3.80 0.26 2.478 0.031
HRV
n 16 23
Wake
RRM (ms) 778.49 20.66 794.71 19.38 0.096 0.571
SDNN (ms) 59.99 4.66 63.69 4.38 0.107 0.567
RMSSD (ms) 30.15 2.74 34.28 3.57 0.313 0.365
ln VLF (WPC) 14.90 0.07 15.04 0.06 0.016 0.128
ln LF (WPC) 10.30 0.13 10.54 0.13 0.251 0.194
ln HF (WPC) 7.71 0.14 7.87 0.12 0.030 0.407
L/H 15.10 1.14 16.59 1.23 0.212 0.380
LF (nu) 0.16 0.06 0.10 0.03 2.951 0.414
HF (nu) 0.84 0.06 0.90 0.03 2.951 0.414
Sleep
RRM (ms) 902.90 31.37 926.33 25.43 0.100 0.566
SDNN (ms) 57.00 5.74 62.20 4.68 0.463 0.488
RMSSD (ms) 31.42 3.19 34.17 2.58 0.886 0.508
ln VLF (WPC) 15.14 0.07 15.31 0.10 0.762 0.167
(Continued)
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TABLE 1 | Continued
CS O-LOAD t p
Mean or frequency SE or % Mean or frequency SE or %
ln LF (WPC) 10.30 0.14 10.48 0.09 2.169 0.263
ln HF (WPC) 7.88 0.16 7.97 0.10 2.048 0.606
L/H 12.32 0.85 14.12 1.30 2.340 0.253
LF (nu) 0.22 0.06 0.22 0.06 0.403 0.946
HF (nu) 0.78 0.06 0.78 0.06 0.403 0.946
Sleep–wake difference
RRM (ms) 130.67 26.37 127.99 20.88 0.067 0.937
SDNN (ms) −1.28 3.56 −2.07 4.14 0.961 0.886
RMSSD (ms) 1.87 2.41 −0.32 3.71 0.723 0.623
ln VLF (WPC) 0.26 0.06 0.26 0.12 2.445 0.997
ln LF (WPC) 0.03 0.08 −0.07 0.14 3.134 0.522
ln HF (WPC) 0.20 0.10 0.11 0.11 1.268 0.806
L/H −2.98 0.99 −2.68 1.22 0.576 0.850
LF (nu) 0.07 0.07 0.12 0.05 0.109 0.558
HF (nu) −0.07 0.07 −0.12 0.05 0.109 0.558
CRQ, Cognitive Reserve Questionnaire; BDI-II, Beck Depression Inventory, second edition; HDRS, Hamilton Depression Rating Scale; ESS, Epworth Sleepiness Scale;
PSQI, Pittsburgh Sleep Quality Index; MMSE, Mini Mental State Examination; RAVLT, Rey Auditory Verbal Learning Test learning curve; RAVLT D, Rey Auditory Verbal
Learning Test delayed recall; RGM, relative gray matter; RWM, relative white matter; HRV, heart rate variability; RRM, mean duration of RR intervals; SDNN, standard
deviation of RR intervals; RMSSD, square root of the mean squared differences of successive normal RR; WPC, power wavelet coefficients corresponding to: VLF, very
low frequency; LF, low frequency; HF, high frequency; L/H, relationship between LF and HF.
TABLE 2 | Correlation coefficients between HRV and neuropsychological measurements.
SDNN RMSSD LF HF L/H
Wake
CRQ ns ns −0.459, 0.028 −0.437, 0.037 ns
RAVLT 0.557, 0.006 0.659, 0.001 0.523, 0.010 0.562, 0.005 ns
RAVLT D 0.504, 0.014 0.579, 0.004 0.489, 0.018 0.541, 0.008 ns
Sleep
Clock ns ns ns ns −0.452, 0.035
MMSE ns ns ns ns −0.524, 0.012
RAVLT ns ns ns ns −0.559, 0.007
RAVLT D ns ns ns ns −0.508, 0.041
Sleep–wake
MMSE ns ns ns ns −0.522, 0.013
RAVLT −0.484, 0.023 −0.445, 0.038 −0.613, 0.002 ns −0.744, <0.001
RAVLT D ns ns −0.575, 0.005 ns −0.713, <0.001
Shown for each variable are: r, p. CRQ, Cognitive Reserve Questionnaire; MMSE, Mini Mental State Examination; RAVLT, Rey Auditory Verbal Learning Test learning curve;
RAVLT D, Rey Auditory Verbal Learning Test delayed recall. In bold are marked r, p surviving Bonferroni correction for multiple measurements.
(see Kemp and Quintana, 2013 for a comprehensive discussion
on the origins and interpretation of HRV).
In the present study, we observed a relationship between
overall HRV and amplitude of the sleep–wake differences of
HRV and better cognition in O-LOAD. More specifically,
greater sympathetic prevalence [as denoted by increased low
frequency/high frequency (L/H)] at night was associated with
more widespread poor results in cognition, including not
only verbal memory but overall cognition (as reflected in the
MMSE score) and visuospatial/executive function (clock drawing
score).A potential link between abnormal sleep–wake variation
and poor cognition in the present sample of O-LOAD might
be the reported association between reduced parasympathetic
activity and decreased sleep quality (Burton et al., 2010),
which in turn predicts cognitive decline (Mander et al., 2016).
Another potential link may be the increased susceptibility to
stress (e.g., Stenfors et al., 2016). However, normal anxiety
and depression symptomatology in O-LOAD argue against
this possibility. Alternatively, recent data suggest that vascular
and endocrine changes might mediate the relationship between
cardiac autonomic activity and cognition (Kemp et al., 2016).
Results in the study by Kemp et al. (2016) might not
be easily comparable to the present study, as they studied
HRV in 10-min samples and the cognitive test was TMT-B.
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Moreover, the normal Hachinski score observed in our O-LOAD
sample makes a similar pathophysiologic link less likely in our
sample. However, other published results emphasize the need to
further investigate the mechanisms linking HRV and cognition.
In the case of O-LOAD, the hypothesis that limbic changes
underlie both cognitive changes and top-down abnormalities
in the control of peripheral autonomic function needs to be
tested with the help of structural and functional regional brain
measurements focusing on structures known to be affected early
in AD.
We could not confirm our prediction of unaffected cognition
in this middle-aged, asymptomatic sample of O-LOAD patients.
Whereas performance in all participants fell in the range
considered normal, delayed recall, learning in the 5th trial, and
recuperation on the RAVLT were lower in O-LOAD than in
CS. This finding was unexpected given that average age was
around 53 years, i.e., approximately a decade prior to the age
of expected onset of symptoms. This lends support to the
hypothesis that significant AD pathology may be present in at-
risk individuals several years prior to cognitive symptom onset
(Braak et al., 2011). Such structural changes could affect limbic
functions as suggested by the associations between cognition and
sleep–wake cycle abnormalities described herein. However, brain
anatomical and functional correlates of these findings will have
to be confirmed in future studies addressing brain volume and
indicators of amyloid deposition in regions known to bear the
early impact of AD pathology.
The present conclusions are limited by a series of factors. The
relatively small number of participants would require that the
present findings be confirmed in larger samples; in particular, we
might have overlooked differences between groups in variables of
limbic functioning due to small sample size. The only available
structural measure was total GM and WM in the encephalon,
adjusted for intracranial volume. There were no significant
differences in these general measures of neurodegeneration, but
regional volumes and brain function measurements were not
ascertained so, as stated, the meaning of the present clinical and
physiological findings in terms of AD pathology remains to be
determined. Albeit significant, correlation values suggest limbic
phenotypes explain only up to 25% of the variance in cognitive
values, leaving a substantial variability explained by other factors.
Last, we observed a trend toward a better cognitive reserve in
controls compared to O-LOAD (Table 1). Albeit not statistically
significant, a better cognitive reserve could explain at least in
part the better performance in memory and vocabulary in this
group, unrelated to the fact of not having a family history of
LOAD.
In sum, the present preliminary results extend previous
observations of a relationship between sleep structure and
cognition in patients with minor and major neurocognitive
disorder due to AD, to cognitively asymptomatic, middle-
aged offspring of individuals with AD. Further, it extends the
observation to a peripheral indicator of the activity of the central
autonomic network, and specifically links autonomic activity
during sleep with cognitive performance. The relationship of
these observations with specific structural alterations in limbic
areas and pattern of amyloid deposit in this group remains
unsettled and opened to further investigation. Further, the
potential utility of variables studied herein as early biomarkers
of AD status would necessitate long-term follow-up in order
to detect those individuals who progress to the development of
clinical characteristics of AD.
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